FDA DEVICE FACTS
MicroMatrix® UBM Particulate
Acell, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
MicroMatrix® UBM Particulate is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. The device is intended for one-time use. Technological Characteristics Compared to Predicate The subject device has the same intended use, design, materials, sterility, and fundamental operation as the predicate devices. The change to extend shelf life to three (3) years, increase in carton size, and addition of MR safe information to the labeling does not impact the technological characteristics of the devices. Summary of Nonclinical and Clinical Testing Performed The following performance testing has been conducted in support of the substantial equivalence determination. The testing utilized well -established methods, including those from FDA consensus standards. All testing was performed on production equivalent devices.
Performance Bench Test Results Test Conclusion Hydrated Onset Temperature Meets Acceptance Criteria Particle Size Analysis Meets Acceptance Criteria Package Integrity - Visual Inspection Meets Acceptance Criteria Package Integrity - Bubble Leak Meets Acceptance Criteria Package Integrity - Seal Strength Meets Acceptance Criteria
Animal Studies No animal studies were required as appropriate verification of the subject devices was achieved based on the comparison to the predicate devices and from the results of the bench testing and engineering analysis.
Clinical Studies No clinical studies were required as appropriate verification of the subject devices was achieved based on the comparison to the predicate devices and from the results of the bench testing and engineering analysis.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。